UnitedHealth Group’s 2024 revenues hit $400.3 billion in 2024 – a 6% year-over-year increase – and full-year earnings from operations were $32.3 billion.
CEO Andrew Witty attributed much of this performance to a strong showing from pharmacy benefit manager OptumRx.
“Pharmacy benefit managers play a vital role in keeping those prices down,” said Witty during Thursday’s Q4 earnings call. “OptumRx alone delivers tens of billions of dollars in savings annually.
